Mr. Newman: We're a rapidly growing nutritional medicine company focused primarily on nursing homes, dialysis clinics and hospitals. We use proprietary technology to develop unique and highly effective concentrated liquid, shelf-stable nutrition medicines that are superior both from a cost standpoint and an efficacy standpoint to currently available alternatives.
TWST: What is this market's current growth potential and actual size?
Mr. Newman: The institutional nutritional supplement market is about $4 billion in the U.S. and growing at over 12% a year. That rate of growth is likely to increase as the over-65 age cohort in the U.S. increases from under 40 million today to 55 million by 2020, and over 70 million by 2030. We are in a position to benefit significantly from that demographic shift because of our particular focus on geriatric care in nursing homes, acute care facilities and dialysis clinics
Tickers included in this excerpt: MDNU
For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.